美迪西(688202) - 2021 Q1 - 季度财报

Financial Performance - Operating revenue for the period was ¥214,726,795.49, representing a 102.81% increase year-on-year[12]. - Net profit attributable to shareholders was ¥45,118,700.74, a significant increase of 195.70% compared to the same period last year[12]. - Basic earnings per share increased to ¥0.73, reflecting a growth of 192.00% compared to the previous year[12]. - Net profit for Q1 2021 was ¥47,403,100.16, representing a 206.5% increase from ¥15,465,601.25 in Q1 2020[49]. - Total operating revenue for Q1 2021 reached ¥214,726,795.49, a significant increase of 102.5% compared to ¥105,877,593.97 in Q1 2020[47]. Cash Flow - Net cash flow from operating activities was ¥22,276,276.28, up 338.72% year-on-year[12]. - The net cash flow from operating activities for Q1 2021 was ¥22,000,672.48, a significant increase from ¥3,627,233.92 in Q1 2020, representing a growth of approximately 507%[59]. - The cash inflow from operating activities totaled ¥192.13 million in Q1 2021, compared to ¥113.10 million in Q1 2020, representing an increase of 69.9%[54]. - The cash outflow from operating activities was ¥169.85 million in Q1 2021, up from ¥108.02 million in Q1 2020, which is a 57.2% increase[57]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,456,002,298.38, an increase of 6.72% compared to the end of the previous year[12]. - Total liabilities amounted to ¥270,429,662.25, compared to ¥228,669,309.25, showing an increase of around 18.2%[37]. - Current assets totaled ¥698,944,415.47, slightly down from ¥699,289,562.44, indicating a decrease of about 0.05%[32]. - Non-current assets rose to ¥757,057,882.91 from ¥665,033,566.75, reflecting an increase of approximately 13.8%[35]. - Total liabilities increased to ¥239,854,004.88 in the latest report, compared to ¥194,052,299.87 previously, marking a 23.6% rise[43]. Research and Development - The proportion of R&D investment to operating revenue decreased to 7.15%, down 1.06 percentage points from the previous year[12]. - R&D expenses increased by 76.6% to ¥15,358,165.05, reflecting the company's investment in enhancing research capabilities[26]. - Research and development expenses for Q1 2021 totaled ¥15,358,165.05, up 76.5% from ¥8,696,529.27 in Q1 2020[47]. Shareholder Information - The total number of shareholders at the end of the reporting period was 3,904[18]. - The top shareholder, Chen Jinzhuang, holds 15.68% of the shares, totaling 9,722,588 shares[18]. - Shareholders' equity reached ¥1,185,572,636.13, up from ¥1,135,653,819.94, indicating a growth of about 4.4%[37]. Expenses - Sales expenses increased by 46.74% to ¥9,083,463.78, primarily due to intensified market expansion efforts[26]. - The company reported a decrease in financial expenses to -¥2,014,144.07, a reduction attributed to improved cash management[26]. - The gross profit margin improved significantly, with operating costs rising by 79.89% to ¥122,011,811.68, driven by increased personnel costs and direct materials[24].